The Ergogenic Effect of Recombinant Human Erythropoietin on V̇O2max Depends on the Severity of Arterial Hypoxemia
2008

The Effect of Erythropoietin on Maximal Oxygen Uptake in Different Levels of Hypoxia

Sample size: 8 publication 10 minutes Evidence: moderate

Author Information

Author(s): Paul Robach, Jose A. L. Calbet, Jonas J. Thomsen, Robert Boushel, Pascal Mollard, Peter Rasmussen, Carsten Lundby

Primary Institution: Ecole Nationale de Ski et d'Alpinisme, Chamonix, France

Hypothesis

How does the rhEpo-induced rise in V̇O2max vary with the severity of hypoxia?

Conclusion

Erythropoietin improves maximal oxygen uptake during moderate hypoxia but not during severe hypoxia.

Supporting Evidence

  • rhEpo treatment increased red blood cell volume by 9.4% after 5 weeks.
  • Maximal oxygen uptake improved by 5.8% after 5 weeks of rhEpo treatment in normoxia.
  • V̇O2max was significantly higher during moderate hypoxia compared to normoxia.
  • At 4500 m, there was no significant increase in V̇O2max after rhEpo treatment.

Takeaway

Erythropoietin helps people use more oxygen when exercising, but only up to a certain point; after that, it doesn't help as much.

Methodology

Eight healthy male volunteers underwent rhEpo treatment and performed exercise tests in different levels of hypoxia.

Potential Biases

Potential bias due to the small number of participants and the specific demographic of healthy male volunteers.

Limitations

The study had a small sample size and the timing difference between non-invasive and invasive studies may affect comparability.

Participant Demographics

Eight Caucasian healthy male volunteers, mean age 27 years.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% CI not specified

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0002996

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication